This inventor holds 1 USPTO granted patent. Top assignee: Celltech Pharma Europe Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Fiona Craig
Fiona Craig is a notable inventor based in Kent, GB. She has made significant strides in the field of medical treatments, particularly focusing on therapies for convulsive states. Her work has the potential to impact the lives of many individuals suffering from conditions such as epilepsy, bipolar disorder, and narcolepsy.
Latest Patents
Fiona Craig holds a patent for the treatment of convulsive states. Her patent, titled "Single enantiomer-threo-methylphenidate is useful in the therapy of a convulsant state," highlights the effectiveness of this compound in managing various neurological disorders. The innovative aspect of her patent is the method of administration, which may be done topically, offering a new approach to treatment.
Career Highlights
Fiona Craig is currently employed at Celltech Pharma Europe Limited, where she continues to develop her research and innovations. Her dedication to improving therapeutic options for patients is evident in her work and contributions to the pharmaceutical industry.
Collaborations
Fiona collaborates with Elizabeth Janina Davidson, who is also a key figure in her research endeavors. Their partnership exemplifies the importance of teamwork in advancing medical innovations.
Conclusion
Fiona Craig's contributions to the field of medical treatments through her patent and work at Celltech Pharma Europe Limited demonstrate her commitment to improving patient care. Her innovative approach to treating convulsive states is a testament to her skills as an inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile